European Archives - Page 281 of 1177 - European Medical Journal

AI Model Predicts Mortality Using Chest CT Findings

AN AI-BASED model can effectively predict all-cause mortality by identifying incidental extrapulmonary findings on chest CT scans according to a recent study.

MRI Biopsy Outperforms Other Techniques for Assessing Breast Abnormalities

This study suggests that contrast-enhanced mammography-guided biopsy is not a suitable substitute for MRI-guided biopsy in evaluating suspicious breast MRI findings

Congress Wrap: ESC 2024

The European Society of Cardiology (ESC) Congress 2024, held in London, UK, was a truly groundbreaking event, bringing together the brightest…

Onc Now: Episode 1: Choices in Cancer Care: Empowering Every Patient

In this podcast, Divyanshu Dua discusses the future of AI in oncology, as well as the importance of treatment options for older patients.

Identify and Manage an Interactive Osteoarthritis Case

Improve your awareness and management of patients with osteoarthritis using this interactive case study on a patient experiencing related symptoms

Potential Biomarker for Predicting Liver Cancer Immunotherapy Success

A recent study explores serum anti-PD-1 autoantibodies as a potential biomarker for predicting survival outcomes in patients with advanced hepatocellular carcinoma

Moderna’s Chantal Friebertshäuser on improving vaccine confidence

The EMJ GOLD podcast is back! Our first guest is Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna.

US to donate 1 million mpox vaccines to Africa amid outbreak

In response to the ongoing mpox outbreak in parts of Africa, the US government has announced a significant donation of 1 million vaccines.

The rise, fall and smart allocation of pharma marketing budgets

This infographic shows how budgets have fluctuated over the years, and where to allocate remaining spend before the end of 2024.

Skin Cancer Trends: Unravelling Melanoma Patterns

This study highlights gender-based differences in melanoma incidence across body sites from 1982–2018 in Australia, the US, and Scotland.